Viewing Study NCT05265793


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-02-23 @ 4:32 AM
Study NCT ID: NCT05265793
Status: UNKNOWN
Last Update Posted: 2022-03-04
First Post: 2021-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None PD-1 Immunotherapy View
None VEGFR-TKI View
None Sarcomatoid Carcinoma View
None Carcinosarcoma View
Keywords: